GBA-associated PD: chances and obstacles for targeted treatment strategies.
Journal Of Neural Transmission (Vienna, Austria : 1996)
Höglinger, Günter G; Schulte, Claudia C; Jost, Wolfgang H WH; Storch, Alexander A; Woitalla, Dirk D; Krüger, Rejko R; Falkenburger, Björn B; Brockmann, Kathrin K
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.
Journal Of Parkinson'S Disease
Peterschmitt, M Judith MJ; Saiki, Hidemoto H; Hatano, Taku T; Gasser, Thomas T; Isaacson, Stuart H SH; Gaemers, Sebastiaan J M SJM; Minini, Pascal P; Saubadu, Stéphane S; Sharma, Jyoti J; Walbillic, Samantha S; Alcalay, Roy N RN; Cutter, Gary G; Hattori, Nobutaka N; Höglinger, Günter U GU; Marek, Kenneth K; Schapira, Anthony H V AHV; Scherzer, Clemens R CR; Simuni, Tanya T; Giladi, Nir N; Sardi, Sergio Pablo SP; Fischer, Tanya Z TZ; ,
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.
Annals Of Neurology
Liu, Ganqiang G; Boot, Brendon B; Locascio, Joseph J JJ; Jansen, Iris E IE; Winder-Rhodes, Sophie S; Eberly, Shirley S; Elbaz, Alexis A; Brice, Alexis A; Ravina, Bernard B; van Hilten, Jacobus J JJ; Cormier-Dequaire, Florence F; Corvol, Jean-Christophe JC; Barker, Roger A RA; Heutink, Peter P; Marinus, Johan J; Williams-Gray, Caroline H CH; Scherzer, Clemens R CR; ,